Results 231 to 240 of about 1,599,857 (245)

Minimal residual disease in acute myeloid leukaemia

Nature Reviews Clinical Oncology, 2013
Christopher S Hourigan, Judith E Karp
exaly  

Prediction of acute myeloid leukaemia risk in healthy individuals

Nature, 2018
Sabina Sieri, Paul M Krzyzanowski, Moritz Gerstung   +2 more
exaly  

Gemtuzumab ozogamicin in acute myeloid leukaemia

Nature Reviews Clinical Oncology, 2012
Hagop Kantarjian
exaly  

Molecular therapy for acute myeloid leukaemia

Nature Reviews Clinical Oncology, 2015
Martin S. Tallman, Ross L Levine, Catherine C Coombs   +2 more
exaly  

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

Nature, 2012
Andrew Kasarskis, Alexander E Perl, Qi Wang   +2 more
exaly  

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult†

Ca-A Cancer Journal for Clinicians, 2002
Richard M Stone
exaly  

Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials

Annals of Oncology, 2005
Livio Pagano, Alberto Bosi, Emanuele Angelucci   +2 more
exaly  

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

Nature, 2014
Terrence N Wong, John S Welch, Andrew L Young   +2 more
exaly  

Functional genomic landscape of acute myeloid leukaemia

Nature, 2018
Christopher R. Cogle, Aurora S Blucher, Daniel A Pollyea   +2 more
exaly  

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
Naval Daver, Courtney D DiNardo, Hagop Kantarjian   +2 more
exaly